Anuh Pharma Ltdhas informed BSE that the meeting of the Board of Directors of the Company is scheduled on 20/05/2026 ,inter alia, to consider and approve Audited Financial Results For The ....
ANUHPHR · price
▲ positive · ▼ negative · ● neutral filings · teal = economic event · numbered = multiple that day (click to pick). Times IST.
Anuh Pharma Ltd has informed BSE and NSE that a Board meeting is scheduled for May 20, 2026 to consider and approve the Audited Financial Results for Q4 and FY 2025-26 (year ended March 31, 2026). The meeting will also consider recommending a dividend for FY 2025-26, approve the Draft Statutory and Secretarial Audit Reports, and review the Director's Report. Additionally, the Board will decide on re-appointments of two directors retiring by rotation (Mr. Bipin Nemchand Shah and Mr. Arun Lalchand Todarwal). The meeting will also fix the date for the AGM and Book Closure Date. No specific financial figures or qualitative opinions are mentioned in this intimation.
This is a routine pre-result announcement notice. Shareholders should note that the trading window remains closed until 48 hours after results declaration (till May 22, 2026). The actual impact on the stock will depend on the financial results and any accompanying disclosures that will be released after the Board meeting.